Efficacy of doxorubicin after progression on carboplatin and paclitaxel in advanced or recurrent endometrial cancer: a retrospective analysis of patients treated at the Brazilian National Cancer Institute (INCA)

Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1–Positive Endometrial Cancer: Results From the KEYNOTE-028 Study

(2017) Patrick A. Ott et al.   JOURNAL OF CLINICAL ONCOLOGY

Second-Line Therapy for Endometrial Cancer: The Need for Better Options

(2015) Gini F. Fleming   JOURNAL OF CLINICAL ONCOLOGY

Uterine Sarcoma, Version 1.2016

(2015) Wui-Jin Koh et al.   Journal of the National Comprehensive Cancer Network

Everolimus as second- or third-line treatment of advanced endometrial cancer: ENDORAD, a phase II trial of GINECO

(2013) I Ray-Coquard et al.   BRITISH JOURNAL OF CANCER

Applicability of the concept of “platinum sensitivity” to recurrent endometrial cancer: The SGSG-012/GOTIC-004/Intergroup study

(2013) Shoji Nagao et al.   GYNECOLOGIC ONCOLOGY

Treatment of Advanced or Recurrent Endometrial Carcinoma With Doxorubicin in Patients Progressing After Paclitaxel/Carboplatin

(2013) Vicky Makker et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Integrated genomic characterization of endometrial carcinoma

(2013) Gad Getz et al.   NATURE

Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2011) N. Colombo et al.   ANNALS OF ONCOLOGY

Phase II Study of Temsirolimus in Women With Recurrent or Metastatic Endometrial Cancer: A Trial of the NCIC Clinical Trials Group

(2011) Amit M. Oza et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase II Trial of Bevacizumab in Recurrent or Persistent Endometrial Cancer: A Gynecologic Oncology Group Study

(2011) Carol Aghajanian et al.   JOURNAL OF CLINICAL ONCOLOGY

The Role of Radiotherapy in Endometrial Cancer: Current Evidence and Trends

(2011) Carien L. Creutzberg et al.   Current Oncology Reports

Second-line chemotherapy for advanced or recurrent endometrial carcinoma previously treated with paclitaxel and carboplatin, with or without epirubicin

(2010) Yutaka Ueda et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Endometrial Carcinoma: A Review of Chemotherapy, Drug Resistance, and the Search for New Agents

(2010) K. M. Moxley et al.   ONCOLOGIST

Node-positive adenocarcinoma of the endometrium: Outcome and patterns of recurrence with and without external beam irradiation

(2009) Ann H. Klopp et al.   GYNECOLOGIC ONCOLOGY

Phase II Trial of Ixabepilone As Second-Line Treatment in Advanced Endometrial Cancer: Gynecologic Oncology Group Trial 129-P

(2009) Don S. Dizon et al.   JOURNAL OF CLINICAL ONCOLOGY